![](https://www.diabetesnews.com/wp-content/uploads/2012/09/drug_research_1-150x150.jpg)
mTOT Modulators: These compounds have been shown to be safe, well-tolerated and effective at lowering glucose in phase 2 clinical studies involving people with Type 2 diabetes. Longer duration, more comprehensive clinical trials will proceed next year.
Read more